Suppr超能文献

药物研发中的新型1,2,4-恶二唑衍生物

Novel 1,2,4-Oxadiazole Derivatives in Drug Discovery.

作者信息

Biernacki Karol, Daśko Mateusz, Ciupak Olga, Kubiński Konrad, Rachon Janusz, Demkowicz Sebastian

机构信息

Department of Organic Chemistry, Faculty of Chemistry, Gdansk University of Technology,Narutowicza 11/12, 80-233 Gdansk, Poland.

Department of Inorganic Chemistry, Faculty of Chemistry, Gdansk University of Technology,Narutowicza 11/12, 80-233 Gdansk, Poland.

出版信息

Pharmaceuticals (Basel). 2020 May 29;13(6):111. doi: 10.3390/ph13060111.

Abstract

Five-membered 1,2,4-oxadiazole heterocyclic ring has received considerable attentionbecause of its unique bioisosteric properties and an unusually wide spectrum of biological activities.Thus, it is a perfect framework for the novel drug development. After a century since the1,2,4-oxadiazole have been discovered, the uncommon potential attracted medicinal chemists'attention, leading to the discovery of a few presently accessible drugs containing 1,2,4-oxadiazoleunit. It is worth noting that the interest in a 1,2,4-oxadiazoles' biological application has been doubledin the last fifteen years. Herein, after a concise historical introduction, we present a comprehensiveoverview of the recent achievements in the synthesis of 1,2,4-oxadiazole-based compounds and themajor advances in their biological applications in the period of the last five years as well as briefremarks on prospects for further development.

摘要

五元1,2,4-恶二唑杂环因其独特的生物电子等排性质和异常广泛的生物活性而受到了广泛关注。因此,它是新型药物开发的理想骨架。自1,2,4-恶二唑被发现一个世纪以来,这种不寻常的潜力吸引了药物化学家的关注,从而发现了一些目前可获得的含有1,2,4-恶二唑单元的药物。值得注意的是,在过去十五年中,人们对1,2,4-恶二唑生物应用的兴趣增加了一倍。在此,在简要介绍历史之后,我们全面概述了基于1,2,4-恶二唑的化合物合成的最新成果以及过去五年中它们在生物应用方面的主要进展,并对进一步发展的前景作简要评论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a87d/7345688/4a77078cabc7/pharmaceuticals-13-00111-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验